Search Medical Condition
Please enter condition
Please choose location from dropdown

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (952) clinical trials

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

Parkinson's disease (PD) is the second most common neurodegenerative illness affecting approximately 1.5 million Americans and is the 14th leading cause of death in the United States. PD is traditionally described as a movement disorder with characteristic motor symptoms (e.g. tremor). However, more recent research demonstrates the impact of nonmotor ...

Phase N/A

Connected Solution of Assistance Dedicated to Caregivers and People With Alzheimer's Disease or Related Diseases

Description of the intervention: Lili Smart solution consists of an application for caregivers (web / mobile), a GSM watch worn by the patient, smart sensors placed at different locations of the patient's home and a support service 24 / 24 and 7/7. Objectives: The main objective is to evaluate the ...

Phase N/A

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

The overall goal of this imaging trial is to evaluate [18F]MNI-958, a tau targeted PET radioligand, in individuals with Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP), and healthy volunteers (HV).

Phase N/A

Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

The specific aims include: Primary aim: Examine the efficacy of exenatide weekly injection in improving negative symptoms as measured by the Scale for the Assessment of Negative Symptoms (SANS) total score. Secondary aims: Examine the efficacy of exenatide in improving cognition as measured by the Measurement and Treatment Research to ...


Cognitive Health in Ageing Register: Investigational Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study

This is a prospective, non-interventional study consisting of a Main Study, a SubStudy, and an Ancillary Study that will enroll participants without dementia who are considered at high, medium, and low risk for developing AD from a community based register (referred to as the CHARIOT registry) in the United Kingdom. ...

Phase N/A

Innovative Ultrasound Technology in Neuromuscular Disease

This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.

Phase N/A

Memory for Action in Neurological Patients

= Folstein et al., 1975, = Zigmond & Snaith, 1983, = Dubois et al., 2002; = Godefroy et al., 2008; = Dubois et Pillon, 2000; = Mahieux-Laurent, 2009.

Phase N/A

Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder

Behavioral interventions currently provide the most useful approach to addressing the behavioral and social needs of those with Mild Cognitive Impairment (MCI) due to Alzheimer's or other diseases. This randomized, multisite, 3-arm study will investigate the impact of computerized brain fitness vs yoga vs an active control group (wellness education) ...

Phase N/A

Mindfulness Group-based Intervention for Early Psychosis

The purpose of this multi-site RCT is to determine the effectiveness of the MAC group intervention on reducing psychotic disorder symptomatology (primary outcome) as well as promoting quality of life, critical skills for recovery and decreasing mental health service utilization (secondary outcomes) for transitional aged youth (16-25 years old) experiencing ...

Phase N/A

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia Schizophreniform or Bipolar I Disorder

In the US adolescent subjects starting at age 16 will be enrolled. In the EU, subjects age 18 and older will be enrolled.